Zepbound® Access & Monitoring Rx
Lose 20% of your body weight with Zepbound®, a once-weekly FDA-approved injection that helps quiet hunger and food noise through dual GIP + GLP-1 support.
- Billed $65/mo for membership
- Rx billed via LillyDirect® starting at $299/mo
- Ongoing provider support & monitoring
- Pause or cancel anytime
Frequently asked questions
Zepbound® is a once-weekly FDA-approved Tirzepatide injection for adults ready for meaningful weight loss of 20-50 lbs. Zepbound® is designed for chronic weight management in adults with obesity, or overweight adults with a weight-related condition like high blood pressure or type 2 diabetes. It’s also FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity.4
Through AgelessRx, Zepbound® comes with a full, in-house team of expert support that helps make treatment easier to start, with provider-guided dosing, ongoing monitoring, and help navigating dose changes and side effects over time.
Zepbound® works on two natural hormone pathways, GIP and GLP-1, that help regulate appetite, fullness, and blood sugar. Hitting both tends to produce a more potent combined effect than either pathway alone. That dual-pathway approach helps quiet hunger, slow digestion, and signal fullness to the brain, making it easier to eat less without feeling like weight loss depends on willpower alone.5
Zepbound® is taken once weekly and works best alongside nutrition changes, regular movement, and provider-guided dose adjustments.
Zepbound® starts low and builds gradually. Most people begin with 2.5mg once weekly for four weeks. From there, your provider may increase your dose in 2.5mg steps about every four weeks, based on how your body responds, how well you tolerate treatment, and what dose makes sense for your goals. The goal isn’t to rush to the highest dose as soon as possible, but rather to find the dose that helps support the best progress while keeping treatment manageable.
Zepbound® is injected once weekly. If prescribed, a US-licensed medical provider will provide a tailored dosage schedule and specific treatment instructions with your care plan.
Important safety information and common side effects
Zepbound® should be used with a reduced-calorie meal plan and increased physical activity. Zepbound® contains Tirzepatide and should not be used with other GLP-1 or GIP receptor agonist medications, or any other products containing Tirzepatide.
Most common side effects
Zepbound® may have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, delayed gastric emptying, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder).
Common side effects normally go away on their own within a few days, or up to 2-3 weeks. If you find that any side effects persist for longer than this or get worse over time, stop taking Zepbound® and contact your prescriber as soon as possible.
Other important safety information
Do not use Zepbound® if you are allergic to Tirzepatide, pregnant or breastfeeding, or planning to become pregnant or breastfeed. Stop taking Zepbound® at least 2 months before trying to conceive.
Zepbound® should not be used by anyone who has a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis.
Tirzepatide may make oral contraceptives less effective. If you’re taking an oral contraceptive, ask your prescriber about potential alternatives before starting Tirzepatide, or switch to a non-oral contraceptive.
Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not GLP-1 products are appropriate for you.
Disclaimer
How it works
- Expert medical review
- Rx access if approved
- Unlimited provider messaging
- Ongoing check-ins
- Pause or cancel anytime
- Save on first two months
- $399/second mo, $449/mo ongoing
- Monthly shipments
- Fulfilled by LillyDirect®
current weight
could lose (lbs)
Average weight loss in 1 year is 20% based on a 72-week clinical trial studying the highest doses of Zepbound® in non-diabetic users with obesity and/or overweight with a weight-related condition, when paired with healthy lifestyle changes.
How Zepbound® works
3 Months
6 Months
9 Months
1 Year and Beyond
What is Zepbound®?
(zehp-bownd)But the medication is only part of the plan. Our expert in-house care team, with 199+ years of combined clinical expertise, helps you start with clarity, adjust safely, and stay supported as your dose changes, side effects come up, and progress builds, so you get the best results.
20% average weight loss in clinical studies.1
Zepbound® vs. Wegovy®
| Zepbound® | Wegovy® |
|---|---|
| Targets both GIP + GLP-1 pathways for dual appetite and metabolic signaling support3 | Targets GLP-1 pathways that help to regulate appetite, fullness, and reduce food noise7 |
| Best for those seeking the strongest available weight-loss option | An established, extensively studied GLP-1 with strong cardiovascular outcomes7 |
| 20% average weight loss | 15% average weight loss |
| $364/first mo | $264/first mo |
| $514/mo ongoing cost | $414/mo ongoing cost |
The above chart is not meant for medical diagnosis purposes. Your prescriber will approve or disapprove a Wegovy® prescription at their discretion after careful consideration of your unique health profile. Approval is not guaranteed based on the above criteria.
Benefits beyond weight loss
More than a prescription. Care for what comes next.
Clinically studied
The science of Zepbound®
Beyond weight loss, Tirzepatide has shown real improvements in blood sugar, blood pressure, and cholesterol, with improved heart outcomes in adults with diabetes and cardiovascular disease.8 Broader effects on long-term cellular aging and inflammation are a genuinely promising area of ongoing research.5 11
Choosing how you age starts here
Connect with a clinician
Get your discreet shipment
Receive continuous support
Disclaimer
Which GLP-1 is right for you?
Frequently asked questions
Zepbound® and Mounjaro® both contain Tirzepatide, but they are approved for different health goals. Mounjaro® is FDA-approved for adults with type 2 diabetes to help manage blood sugar. Zepbound® is FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. Same active ingredient, but different approved uses.4
Zepbound® and Wegovy® are both once-weekly FDA-approved weight loss injections, but they use different active ingredients.
Most GLP-1 medications activate a single hormone pathway. Zepbound® activates two–GIP and GLP-1–at once, which is why it tends to produce greater weight loss and often better tolerability in head-to-head trials than single-pathway options.3
In clinical studies, adults taking Zepbound® lost up to 20.9% of their body weight on average, depending on dose.1 For someone starting at 200 pounds, that would mean about 42 pounds.
Many see meaningful movement by 3 months, with most reaching a maintenance dose and steadier progress by 6 months.1
Individual results vary based on dose, lifestyle, treatment consistency, side effects, and how your body responds.
Some lean-mass loss is a normal part of any significant, relatively fast weight loss, and this isn’t unique to Tirzepatide. It’s also substantially preventable: adequate protein intake and resistance training meaningfully protect muscle during treatment, which is why nutrition guidance is part of your program, not an afterthought.12